+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

bioMerieux SA (BIM) - Product Pipeline Analysis, 2021 Update

  • ID: 5367336
  • Company Profile
  • June 2021
  • 74 pages
  • GlobalData
  • bioMerieux SA

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson and Co
  • Bio-Rad Laboratories Inc
  • Danaher Corp
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents, and software for the diagnosis of infectious diseases, cardiovascular diseases, and cancers and identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical, and cosmetics industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora which indicate the quality of food products. The company distributes its products directly and through a network of distributors across the world. bioMerieux is headquartered in Marcy l’Etoile, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company bioMerieux SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson and Co
  • Bio-Rad Laboratories Inc
  • Danaher Corp
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
bioMerieux SA Company Overview
  • bioMerieux SA Company Snapshot
  • bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
  • bioMerieux SA - Pipeline Analysis Overview
  • Business Description
  • bioMerieux SA - Key Facts
  • bioMerieux SA - Major Products and Services
  • bioMerieux SA Pipeline Products by Development Stage
  • bioMerieux SA Ongoing Clinical Trials by Trial Status
bioMerieux SA Pipeline Products Overview
  • Annexin A3 Prostate Cancer Marker
  • Annexin A3 Prostate Cancer Marker Product Overview
  • ARGENE SARS-COV-2 R-GENE Test
  • ARGENE SARS-COV-2 R-GENE Test Product Overview
  • Biomarker Test - Chronic Q Fever
  • Biomarker Test - Chronic Q Fever Product Overview
  • BRAF - Breast Cancer Diagnostic Kit
  • BRAF - Breast Cancer Diagnostic Kit Product Overview
  • Companion Diagnostic Test - Hormone-Dependent Breast Cancer
  • Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
  • Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
  • Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
  • Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
  • Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
  • Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
  • Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
  • Diagnostic Assay - Prostate Cancer
  • Diagnostic Assay - Prostate Cancer Product Overview
  • Diagnostic Test - Abdominal Pain
  • Diagnostic Test - Abdominal Pain Product Overview
  • Diagnostic Test - Acute Coronary Syndrome
  • Diagnostic Test - Acute Coronary Syndrome Product Overview
  • Diagnostic Test - Acute Respiratory Infection
  • Diagnostic Test - Acute Respiratory Infection Product Overview
  • Diagnostic Test - Cerebrovascular Injury
  • Diagnostic Test - Cerebrovascular Injury Product Overview
  • Diagnostic Test - Sepsis
  • Diagnostic Test - Sepsis Product Overview
  • Diagnostic Test - Tuberculosis
  • Diagnostic Test - Tuberculosis Product Overview
  • FilmArray 2.0 - Lower Respiratory Tract Panel
  • FilmArray 2.0 - Lower Respiratory Tract Panel Product Overview
  • FilmArray 2.0 - Lower Respiratory Tract Panel Clinical Trial
  • FilmArray Febrile Infant Panel
  • FilmArray Febrile Infant Panel Product Overview
  • FilmArray Sepsis Direct Panel
  • FilmArray Sepsis Direct Panel Product Overview
  • FilmArray STD Panel
  • FilmArray STD Panel Product Overview
  • iMAG
  • iMAG Product Overview
  • NEPHROCLEAR CCL14 Test
  • NEPHROCLEAR CCL14 Test Product Overview
  • NEPHROCLEAR CCL14 Test Clinical Trial
  • NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
  • NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
  • NucliSENS EasyQ Legionella spp Molecular Test
  • NucliSENS EasyQ Legionella spp Molecular Test Product Overview
  • NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
  • NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
  • Vidas 3 Immunoanalyzer - Nephrocheck
  • Vidas 3 Immunoanalyzer - Nephrocheck Product Overview
  • VIDAS CXCL9 CDx
  • VIDAS CXCL9 CDx Product Overview
  • VIDAS hsCRP Assay
  • VIDAS hsCRP Assay Product Overview
  • VIDAS TB-IGRA
  • VIDAS TB-IGRA Product Overview
  • VITEK MS PRIME
  • VITEK MS PRIME Product Overview
bioMerieux SA - Key Competitors

bioMerieux SA - Key Employees
  • bioMerieux SA - Key Employee Biographies
bioMerieux SA - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • bioMerieux SA, Recent Developments
  • Jun 02, 2020: Teklynx labeling software teklynx central increases labeling accuracy & compliance by 100% for global biotechnology company bioMerieux
  • Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
  • Mar 12, 2020: Covid-19: BioMerieux launches three coronavirus tests
  • Feb 26, 2020: bioMerieux - 2019 financial results
  • Jan 14, 2020: bioMerieux submits enhanced BIOFIRE BCID2 panel for FDA clearance
  • Oct 22, 2019: bioMerieux - Third quarter 2019 business review
  • Sep 04, 2019: bioMerieux announces First-Half 2019 Results
  • May 13, 2019: NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS “Guidelines for Perioperative Care in Cardiac Surgery”
  • Apr 24, 2019: bioMerieux: First-quarter 2019 business review
  • Apr 04, 2019: Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
  • bioMerieux SA Pipeline Products by Equipment Type
  • bioMerieux SA Pipeline Products by Indication
  • bioMerieux SA Ongoing Clinical Trials by Trial Status
  • bioMerieux SA, Key Facts
  • bioMerieux SA, Major Products and Services
  • bioMerieux SA Number of Pipeline Products by Development Stage
  • bioMerieux SA Pipeline Products Summary by Development Stage
  • bioMerieux SA Ongoing Clinical Trials by Trial Status
  • bioMerieux SA Ongoing Clinical Trials Summary
  • Annexin A3 Prostate Cancer Marker - Product Status
  • Annexin A3 Prostate Cancer Marker - Product Description
  • ARGENE SARS-COV-2 R-GENE Test - Product Status
  • ARGENE SARS-COV-2 R-GENE Test - Product Description
  • Biomarker Test - Chronic Q Fever - Product Status
  • Biomarker Test - Chronic Q Fever - Product Description
  • BRAF - Breast Cancer Diagnostic Kit - Product Status
  • BRAF - Breast Cancer Diagnostic Kit - Product Description
  • Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
  • Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
  • Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
  • Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
  • Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
  • Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
  • Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
  • Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
  • Diagnostic Assay - Prostate Cancer - Product Status
  • Diagnostic Assay - Prostate Cancer - Product Description
  • Diagnostic Test - Abdominal Pain - Product Status
  • Diagnostic Test - Abdominal Pain - Product Description
  • Diagnostic Test - Acute Coronary Syndrome - Product Status
  • Diagnostic Test - Acute Coronary Syndrome - Product Description
  • Diagnostic Test - Acute Respiratory Infection - Product Status
  • Diagnostic Test - Acute Respiratory Infection - Product Description
  • Diagnostic Test - Cerebrovascular Injury - Product Status
  • Diagnostic Test - Cerebrovascular Injury - Product Description
  • Diagnostic Test - Sepsis - Product Status
  • Diagnostic Test - Sepsis - Product Description
  • Diagnostic Test - Tuberculosis - Product Status
  • Diagnostic Test - Tuberculosis - Product Description
  • FilmArray 2.0 - Lower Respiratory Tract Panel - Product Status
  • FilmArray 2.0 - Lower Respiratory Tract Panel - Product Description
  • FilmArray 2.0 - Lower Respiratory Tract Panel - Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-acquired Pneumonia
  • FilmArray Febrile Infant Panel - Product Status
  • FilmArray Febrile Infant Panel - Product Description
  • FilmArray Sepsis Direct Panel - Product Status
  • FilmArray Sepsis Direct Panel - Product Description
  • FilmArray STD Panel - Product Status
  • FilmArray STD Panel - Product Description
  • iMAG - Product Status
  • iMAG - Product Description
  • NEPHROCLEAR CCL14 Test - Product Status
  • NEPHROCLEAR CCL14 Test - Product Description
  • NEPHROCLEAR CCL14 Test - A Sample Collection Study to Validate the NEPHROCLEAR CCL14 Test
  • NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
  • NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
  • NucliSENS EasyQ Legionella spp Molecular Test - Product Status
  • NucliSENS EasyQ Legionella spp Molecular Test - Product Description
  • NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status
  • NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description
  • Vidas 3 Immunoanalyzer - Nephrocheck - Product Status
  • Vidas 3 Immunoanalyzer - Nephrocheck - Product Description
  • VIDAS CXCL9 CDx - Product Status
  • VIDAS CXCL9 CDx - Product Description
  • VIDAS hsCRP Assay - Product Status
  • VIDAS hsCRP Assay - Product Description
  • VIDAS TB-IGRA - Product Status
  • VIDAS TB-IGRA - Product Description
  • VITEK MS PRIME - Product Status
  • VITEK MS PRIME - Product Description
bioMerieux SA, Key Employees
  • bioMerieux SA, Key Employee Biographies
  • bioMerieux SA, Subsidiaries
  • Glossary
List of Figures
  • bioMerieux SA Pipeline Products by Equipment Type
  • bioMerieux SA Pipeline Products by Development Stage
  • bioMerieux SA Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Danaher Corp
  • Siemens Healthineers AG
  • OpGen Inc
  • Thermo Fisher Scientific Inc
  • Sysmex Corp
  • Bio-Rad Laboratories Inc
  • Ortho Clinical Diagnostics Holdings Plc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Eurofins Scientific SE
  • Becton Dickinson and Co
Note: Product cover images may vary from those shown
Adroll
adroll